Trial intelligence / Profile preview

Paclitaxel + Cisplatin vs Cisplatin + 5-FU in Advanced Head and Neck Cancer

NCT00002888Phase 3Completed

Sponsor
Eastern Cooperative Oncology Group
Start
Mar 1997
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of paclitaxel in head and neck cancer (HNC), sponsored by Eastern Cooperative Oncology Group. Started Mar 1997; status: completed.

02

Drugs

paclitaxel
03

Conditions

head and neck cancer (HNC)

Beyond the preview

Go deeper on NCT00002888.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002888.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call